Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 December;58(4) > Panminerva Medica 2016 December;58(4): 349-50

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

LETTERS TO THE EDITOR  


Panminerva Medica 2016 December;58(4): 349-50

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Extension of the stability of anticancer drugs in pharmaceutical practice

Francesca BARATTA 1, Franca GOFFREDO 2, Laura ANNARATONE 3, Anna SAPINO 3, Oscar BERTETTO 4, Paola BRUSA 1

1 Department of Science and Pharmaceutical Technology, University of Turin, Turin, Italy; 2 Oncology Foundation of Piedmont Region, Institute for Cancer Research and Treatment (IRCC), Candiolo, Turin, Italy; 3 Department of Medical Sciences, University of Turin, Turin, Italy; 4 Interaziendale Interregionale Rete Oncologica Piemonte e Valle d’Aosta Department, A.O.U. Città della Salute e della Scienza, Turin, Italy


PDF  


top of page

Publication History

Cite this article as

Baratta F, Goffredo F, Annaratone L, Sapino A, Bertetto O, Brusa P. Extension of the stability of anticancer drugs in pharmaceutical practice. Panminerva Med 2016 December;58(4): 349-50. 

Corresponding author e-mail

francesca.baratta@unito.it